Results 121 to 130 of about 1,484,561 (230)
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type ...
Pollanen,, Jari +20 more
core
RERF Conformational Preferenc from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung ...
Mario De Rosa (15040481) +12 more
core +1 more source
Supplementary Figure 1 from Urokinase Plasminogen Activator Receptor and/or Matrix Metalloproteinase-9 Inhibition Induces Apoptosis Signaling through Lipid Rafts in Glioblastoma Xenograft ...
Jeffrey D. Klopfenstein (7925075) +9 more
core +1 more source
Supplementary Figure 3 from Urokinase Plasminogen Activator Receptor and/or Matrix Metalloproteinase-9 Inhibition Induces Apoptosis Signaling through Lipid Rafts in Glioblastoma Xenograft ...
Jeffrey D. Klopfenstein (7925075) +9 more
core +1 more source
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors [PDF]
Blasi, F. +2 more
openaire +3 more sources
The present invention relates to a method of inducing cancer cells into dormancy and treating cancer in a subject. This method involves administering to a subject an effective amount of a compound that disrupts interaction between urokinase plasminogen ...
Aguirre-Ghiso Julio, A +4 more
core
Soluble urokinase plasminogen activator receptor across the kidney-cardiometabolic continuum: a systematic review. [PDF]
Wu Q, Yu Z, Lin X, Yang L, Wu Z.
europepmc +1 more source
Soluble urokinase plasminogen activator receptor - What are the clinical potentials in psychiatry? [PDF]
Huber FG +4 more
europepmc +1 more source
Circulating Soluble Urokinase Plasminogen Activator Receptor and C-Reactive Protein Concentrations in Adults with High-Functioning Autism. [PDF]
Kurtulmuş A +3 more
europepmc +1 more source

